Por favor, usa este identificador para citar o enlazar este ítem: http://hdl.handle.net/10668/10106
Título : Homocysteine pre-treatment increases redox capacity in both endothelial and tumor cells.
Autor : Díaz-Santiago, Elena
Rodríguez-Caso, Luis
Cárdenas, Casimiro
Serrano, José J
Quesada, Ana R
Medina, Miguel Ángel
Palabras clave : Bovine aortic endothelial cells;Cysteine;Homocysteine;Homocysteine thiolactone;MDA-MB231 breast cancer cell;Redox
MeSH: Antioxidants
Cell Line, Tumor
Endothelial Cells
Homocysteine
Humans
Neoplasms
Oxidation-Reduction
Fecha de publicación : 19-may-2016
Abstract: We studied the modulatory effects of homocysteine pre-treatment on the disulfide reduction capacity of tumor and endothelial cells. Human MDA-MB-231 breast carcinoma and bovine aorta endothelial cells were pre-treated for 1-24 hours with 0.5-5 mM homocysteine or homocysteine thiolactone. After washing to eliminate any rest of homocysteine or homocysteine thiolactone, cell redox capacity was determined by using a method for measuring disulfide reduction. Homocysteine pre-treatments for 1-4 hours at a concentration of 0.5-5 mM increase the disulfide reduction capacity of both tumor and endothelial cells. This effect cannot be fully mimicked by either cysteine or homocysteine thiolactone pre-treatments of tumor cells. Taken together, our data suggest that homocysteine can behave as an anti-oxidant agent by increasing the anti-oxidant capacity of tumor and endothelial cells.
URI: http://hdl.handle.net/10668/10106
DOI: 10.1080/13510002.2016.1183348
Aparece en las colecciones: Producción 2020

Ficheros en este ítem:
No hay ficheros asociados a este ítem.


Este ítem está protegido por copyright original



Los ítems del Repositorio Institucional de Salud de Andalucía están bajo licencia Creative Common Reconocimiento-NoComercial-SinObraDerivada, a menos que se indique lo contrario.